Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Filings indexed 418 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report
2026-05-14 English
FORM S-3/A
Registration Form
2026-05-14 English
424B3 - ARTELO BIOSCIENCES, INC. (0001621221) (Filer)
Prospectus
2026-04-16 English
S-1 - ARTELO BIOSCIENCES, INC. (0001621221) (Filer)
Registration Form
2026-04-07 English
8-K - ARTELO BIOSCIENCES, INC. (0001621221) (Filer)
Regulatory Filings
2026-04-07 English
D - ARTELO BIOSCIENCES, INC. (0001621221) (Filer)
Regulatory Filings
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.